Skip to main content
SpringerLink
Log in

The Evolutionary Pattern of Primary Sclerosing Cholangitis: From a Benign to Severe Disease

  • Chapter
Advances in Abdominal Surgery 2002

  • 102 Accesses

Abstract

The natural history of primary sclerosing cholangitis (PSC) is, to say the least, puzzling in its variability, in terms of age of onset, symptoms and prognosis.[1–2] As a matter of fact there are several, unfortunately independent areas of observation: the Doctor following a patient with Ulcerative Colitis (UC) or Crohn’s Disease (CD), who sees quite a benign increase of serum alkaline phosphatase (sALP) and is not worried about it, the Hepatologist who is quite happy to have found a rare disease, or the Endoscopist willing to perform exploration and diagnosis, but little interested in the radiologic aspect.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79: 200–206.

    PubMed  CAS  Google Scholar 

  2. Chapman RW, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21: 870–877.

    Article  PubMed  CAS  Google Scholar 

  3. LaRusso NF, et al. Current concepts. Primary sclerosing cholangitis. New England Journal of Medicine 1984; 310: 899–903.

    Article  PubMed  CAS  Google Scholar 

  4. Lee YM, Kaplan MM.. Primary sclerosing cholangitis. New England Journal of Medicine 1995; 332: 924–933.

    Article  PubMed  CAS  Google Scholar 

  5. Wiesner RH, et al. Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis. Gastroenterology 1986; 90(2):3 16–22.

    Google Scholar 

  6. Farrant JM, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100(6):1 710–717.

    Google Scholar 

  7. Broome U, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610–615.

    Article  PubMed  CAS  Google Scholar 

  8. Porayko MK, et al. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease [see comments]. Gastroenterology 1990; 98 (6): 1594–1602.

    PubMed  CAS  Google Scholar 

  9. Wiesner RH, Grambsch PM, Dickson ER, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430–436.

    Article  PubMed  CAS  Google Scholar 

  10. Dickson ER, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992; 103: 1893–1901.

    PubMed  CAS  Google Scholar 

  11. Bacosi M, et al. Follow up of 53 consecutive patients with PRIMARY SCLEROSING CHOLANGITIS from a single I.B.D. clinic. Hepatology 2000; 32: in press.

    Google Scholar 

  12. Okolicsanyi L, et al. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicenter study. Eur.J.Gastroenterol. Hepatol 1996; 8: 685–691.

    PubMed  CAS  Google Scholar 

  13. Boberg KM, et al. Natural history of primary sclerosing cholangitis. A long term follow-up study of 394 European primary sclerosing cholangitis patients. JHepatol 2000; 33: in press.

    Google Scholar 

  14. Schrumpf E, Abdelnoor M, Fausa O, Elgio K, Jenssen E, Koimannskog F. Risk factors in primary sclerosing cholangitis. JHepatol 1994; 24: 1061–1066.

    Article  Google Scholar 

  15. Boberg KM, Fausa O, Haaland T, et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 1996; 23: 1369–1376.

    Article  PubMed  CAS  Google Scholar 

  16. Mieli Vergani G, Lobo Yeo A, McFarlane BM, et al. Different immune mechanisms lead to autoimmunity in primary sclerosing cholangitis and autoimmune chronic hepatitis of childhood. Hepatology 1989; 9: 198–203.

    Article  PubMed  Google Scholar 

  17. Wilschamsk M, Chait P, Wade JA, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory and radiographic features, with survival analysis. Hepatology 1995; 22: 1415–1422.

    Google Scholar 

  18. Chapman RW, Varzhese Z, Gaul R, et al. Anti-neutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood. Gut 1993; 34: 199–202.

    Article  PubMed  Google Scholar 

  19. Dienes HP, Lohse AW, Gerken G, et al. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 1997; 431: 119–124.

    Article  PubMed  CAS  Google Scholar 

  20. Hashimoto E, Lindor KD, Homburger HA, et al. Immunohistochemical caracterization of hepatic linphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 1993; 68: 1049–1055.

    Article  PubMed  CAS  Google Scholar 

  21. Washington K, Clavien PA, Killenberg P. Peribiliary vascular plexus in primary sclerosing cholangitis. Histopathology 1991; 19: 321–327.

    Article  Google Scholar 

  22. Sanchez Urdapzal L, Gores GJ, Ward EM, et al. Diagnostic features and clinical outcome of ischemic-type biliary complications after transplantation. Hepatology 1993; 17: 605–609.

    Article  Google Scholar 

  23. Kubota T, Thomson A, Clouston AD, et al. Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation. JHepatobiliary PancreatSurg 1999; 6: 337–381.

    Google Scholar 

  24. Dickson ER, Murtaugh PA, Wiesner RH, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992; 103: 1893–1901.

    PubMed  CAS  Google Scholar 

  25. Farrant JM, Hayilar KM, Wilkinson ML, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710–1717.

    PubMed  CAS  Google Scholar 

  26. Shetty K, Rybicki L, Carey WO. The Chiid-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997; 25: 1049–1053.

    Article  PubMed  CAS  Google Scholar 

  27. Dickson ER, et al. Primary sclerosing cholangitis. Refinement and validation of survival models. Gastroenterology 1992; 103: 1893–1901.

    PubMed  CAS  Google Scholar 

  28. Kaya M, Petersen BT, Angulo P, Lindor KD. Balloon dilatation compared to stenting of dominant strictures in primary sclerosing cholangitis. Gastroenterology 2000; 118: (AGA, San Diego, CA, abstract form).

    Google Scholar 

  29. Angulo P, et al. Time course of histological progression in primary sclerosing cholangitis. American Journal of Gastroenterology I999; 94(1 I):33 10–13.

    Google Scholar 

  30. Locke GR, 3rd, et al. Time course of histological progression In primary biliary cirrhosis. Hepatology 1996; 23 (1): 52–56.

    Article  PubMed  Google Scholar 

  31. Wee A, Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Annals ofInternal Medicine 1985; 102 (5): 581–587.

    CAS  Google Scholar 

  32. Angulo P, Maor-Kendler, Donunger JJ, Lindor KD. Small-duct primary sclerosing cholangitis: prevalence and natural history. (accepted for poster presentation, DDW May 2000, San Diego, CA).

    Google Scholar 

  33. Broome U, Lindberg G, Lôfberg R. Primary sclerosing cholangitis in ulcerative colitis: a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology 1992; 102: 1877–1880.

    PubMed  CAS  Google Scholar 

  34. Broome U, Lofberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995; 22: 1404–1408.

    PubMed  CAS  Google Scholar 

  35. Brentnaii TA, Haggitt RC, Rabinovitch PS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110: 331–338.

    Article  Google Scholar 

  36. O’Haens GR, Lashner BA, Hanauer SB. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroentero 1993; 88: 1174–1178.

    Google Scholar 

  37. Leidenius MH, Farkkila MA, Karkkainen P, et al. Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis. Scand J Gastroentero 1997; 32: 706–711.

    Article  CAS  Google Scholar 

  38. Kornfeld O, Ekbom A, ihre T. Is there an increased risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut I997; 41: 522–525.

    Google Scholar 

  39. Gurbuz AK, Giardiello FM, Bayless TM. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum 1995; 38: 37–41.

    Article  PubMed  CAS  Google Scholar 

  40. Loftus EV Jr, Sandborn WJ, Tremaine WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996; 110: 432–440.

    Article  PubMed  Google Scholar 

  41. Nuako KW, Ahlquist OA, Sandborn WJ, et al. Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: a case-control study. Cancer 1998; 82: 822–826.

    Article  PubMed  CAS  Google Scholar 

  42. Ekbom A, Helmick C, Zack M, Adami H. Ulcerative colitis and colorectal cancer. NEngl JMed 1990; 323: 1228–1233.

    Article  CAS  Google Scholar 

  43. Sandborn WJ, Loftus EV Jr, Ahlquist OA. Association of primary sclerosing cholangitis and colorectal cancer in patients with ulcerative colitis: is it true and does it matter? Gastroenterology 1998; 115: 236–237.

    Article  PubMed  CAS  Google Scholar 

  44. Marchesa P, Lashner BA, Lavery IC, et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterology 1997; 92: 1285–1288.

    CAS  Google Scholar 

  45. Shetty K, Rybicki L, Brzezinski A, Carey WO, Lashner BA. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am JGastroenterol 1999; 94: 1643–1649.

    Article  CAS  Google Scholar 

  46. Lindberg B, Broomé U, Persson B. Proximal colorectal dysplasia/cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalzine: Results from a 20-year surveillance study. Dis Colon Rectum 2000; in press.

    Google Scholar 

  47. Bleday R, Lee E, Jessurun J, et al. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993; 36: 908–912.

    Article  PubMed  CAS  Google Scholar 

  48. Higashi H, Yanaga K, Marsh JW, et al. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990; 11: 477–480.

    Article  PubMed  CAS  Google Scholar 

  49. Knechtle SJ, D’Alessandro AM, Harms BA, et al. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 1995; 118: 615–619.

    Article  PubMed  CAS  Google Scholar 

  50. Lee JG, Schutz SM, England RE, et al. Endoscopic therapy of sclerosing cholangitis. Hepatology 1995; 21: 661.

    PubMed  CAS  Google Scholar 

  51. Ahrendt SA, Pitt HA. Surgical treatment for primary sclerosing cholangitis. Journal of Hepatobiliary and Pancreatic Surgery 1999; 6: 366–372.

    Article  CAS  Google Scholar 

  52. Myburgh JA. Surgical biliary drainage in primary sclerosing cholangitis. The role of the Hepp-Couinaud approach. Archives of Surgery 1994; 129: 1057–1062.

    Google Scholar 

  53. Gordon R, Shaw B, Iwatsuki S, et.al. Indications for liver transplantation in the cyclosporine era. Surg Clin North Am 1986; 66: 541–556.

    PubMed  CAS  Google Scholar 

  54. Sekido H, Takeda K, Morioka D, et al. Liver transplantation for primary sclerosing cholangitis. Journal of Hepatobiliary and Pancreatic Surgery 1999; 6: 373–376.

    Article  CAS  Google Scholar 

  55. Belle S, Detre K. Report from the Pitt-UNOS liver transplant registry. Transplant Pros 1993; 25: 1137–1142.

    CAS  Google Scholar 

  56. Wiesner RH, Porayko MK, Hay JE, et al. Liver transplantation for primary sclerosing cholangitis. Impact of risk factors on out come. Liver Transplantation and Surgery 1996; 2: 99–108.

    Article  PubMed  CAS  Google Scholar 

  57. Graziadei IW, Weisner RH, Marotta PJ, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999; 30: 1 121–127.

    Google Scholar 

  58. Graziadei IW, Weisner RH, Batts KP, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999; 29: 1050–1056.

    Article  PubMed  CAS  Google Scholar 

  59. Iwatsuki S, Starzl T, Van Thiel D, et al. Liver transplantation for sclerosing cholangitis. Gastroenterology 1991; 90: 1736–1742.

    Google Scholar 

  60. Sheng R, Campbell WL, Zajko AB, et al. Cholangiographic features of stricture after liver transplantation for primary sclerosing cholangitis: Evidence of recurrent disease. American Journal of Roentgenology 1996; 166: 1109–1113.

    PubMed  CAS  Google Scholar 

  61. Balan V, Abu-Elmagd K, Demtris AJ. Autoimmune liver diseases: Recurrence after liver transplantation. Surgical Clinics of North America 1999; 79: 147–152.

    Article  PubMed  CAS  Google Scholar 

  62. Harrison R, Hubscher S. Sclerosing cholangitis in liver allografts: a historical perspective Abstract. JPathology 1992; 168 (suppl): 150A.

    Google Scholar 

  63. Ahrendt SA, Pitt HA. Surgical treatment for primary sclerosing cholangitis. Journal of Hepatobiliary and Pancreatic Surgery 1999; 6: 366–372.

    Article  CAS  Google Scholar 

  64. Kim WR, Weisner RH, Poterucha JB, et al. Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization. Hepatology 1999; 30: 395–400.

    Article  PubMed  CAS  Google Scholar 

  65. LaRusso NF, Wiesner RH, Ludwig J, et al. Primary sclerosing cholangitis. N Engl JMed 1984; 310: 899–903.

    Article  CAS  Google Scholar 

  66. Wiesner R. Primary sclerosing cholangitis: Minimal listing criteria for liver transplantation. (Abstract) ASTP Consensus Conference, Bethesda, Maryland 1997.

    Google Scholar 

  67. Mirza DF, Davies M, Oliff S. Preoperative diagnosis of cholangiocarcinoma in primary sclerosing cholangitis in potential liver transplant candidates (Abstract). Hepatology 1994; 20: 1 54A.

    Google Scholar 

  68. Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108 (3): 865–869.

    Article  PubMed  CAS  Google Scholar 

  69. Chalasani N, Baluyut A, Ismail A, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case control study. Hepatology 2000; 3 1: 7–11.

    Article  Google Scholar 

  70. Abu-Elmagd K, Selby R, Iwatsuki S, et al. Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993; 25: 1124–1125.

    PubMed  CAS  Google Scholar 

  71. Nashan B, Schliff HJ, Tusch G, et al. Biliary malignancies in primary sclerosing cholangitis: Timing of liver transplantation. Hepatology 1996; 23; 1105–1111.

    Article  PubMed  CAS  Google Scholar 

  72. Mirza DF, Davies M, Oliff S. Preoperative diagnosis of cholangiocarcinoma in primary sclerosing cholangitis in potential liver transplant candidates. Hepatology 1994; 20: 154 (A).

    Google Scholar 

  73. Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108: 865–869.

    Article  PubMed  CAS  Google Scholar 

  74. Chalasani N, Baluyut A, Ismail A, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case control study. Hepatology 2000; 31: 7–11.

    Article  PubMed  CAS  Google Scholar 

  75. Abu-Elmagd K, Selby R, Iwatsuki S, et al. Cholangiocaricnoma and sclerosing cholangitis: climcal characteristics and effect on survival after liver transplantation. Transplant Proc 1993; 25: 1124–1125.

    PubMed  CAS  Google Scholar 

  76. Nashan B, Schlitt HJ, Tusch G, et al. Biliary malignancies in primary sclerosing cholangitis: Timing of liver transplantation. Hepatology 1996; 23: 1105–1111.

    Article  PubMed  CAS  Google Scholar 

  77. Tannapfel A, Weinans L, Geissler F, Schutz A, Katalinic A, Kockerling F, Hauss J, Wittekind C. Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver. Digestive Diseases Sciences 45: 317–324.

    Google Scholar 

  78. Hidaka E, Yanagisawa A, Seki M, Takano K, Setoguchi T, Kato Y. High frequency of K-ras mutations in biliary duct carcinomas of cases with a ion common channel in the papilla of Vater. Cancer Research 2000; 60: 522–524.

    PubMed  CAS  Google Scholar 

  79. Rijken AM, Hu J, Perlman EJ, Morsberger LA, Long P, Kern SE, Hruban RH, Yeo CJ, Griffin CA. Genomic alterations in distai bile duct carcinoma by comparative genomic hybridization and karyotype analysis. Genes, Chromosomes Cancer 1999; 26: 185–191.

    Article  CAS  Google Scholar 

  80. Itoi T, Ohyashiki K, Yahata N, Shinohara Y, Takei K, Takeda K, Nagao K, Hisatoml H, Ebihara Y, Shay JW, Salto T. Detection of telomerase activity in exfoliated cancer cells obtained from bile. International Journal of Oncology 1999; 15: 1061–1067.

    PubMed  CAS  Google Scholar 

  81. Yokoyama Y, Hiyama E, Murakami Y, Matsuura Y, Yokoyama T. Lack of CD44 variant 6 expression in advanced extrahepatic bile ductlar ampullary carcinoma. Cancer 1999; 86 (9): 1691–1699.

    Article  PubMed  CAS  Google Scholar 

  82. Kamikawa T, Amenomori M, Itoh T, Momoi H, Hiai H, Machinami R, Ishikawa Y, Mori T, Shimahara Y, Yamaoka Y, Fukumoto M. Analysis of genetic changes in intrahepatic cholangiocarcinoma induced by thorotrast. Radiation Research 1999; 152 (6 Suppl):S 118–124.

    Article  Google Scholar 

  83. Ahrendt SA, Eisenberger CF, Yip L, Rashid A, Chow JT, Pitt HA, Sidransky D. Chromosome 9p21 and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. Journal of Surgical Research 1999; 84 (1): 88–93.

    Article  PubMed  CAS  Google Scholar 

  84. Tannapfel A, Engeland K, Weinans L, Katalinic A, Hauss J, Mossner J, Wittekind C. Expression of p73, a novei protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. British Journal of Cancer 1999; 80 (7): 1069–1074.

    Article  PubMed  CAS  Google Scholar 

  85. Sturm PD, Rauws EA, Hruban RH, Caspers E, Ramsoekh TB, Huibregtse K, Noorduyn LA, Offerhaus GJ. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct. Clinical Cancer Research 1999; 5 (3): 629–635.

    PubMed  CAS  Google Scholar 

  86. Kang YK, Kim WH, Lee HW, Lee HK, Kim YI. Mutation of p53 and K-ras, and 1055 of heterozygosity of APC in intrahepatic cholangiocarcinoma. Laboratory Investigation 1999; 79 (4): 477–483.

    PubMed  CAS  Google Scholar 

  87. Jachino C, Catsicojannis N, Dallera F. Prognostic significance of tumor DNA content in carcinoma of the hepatic duct confluence. Journal of Experimental Clinical Cancer Research 1998; 17(4)425–430.

    Google Scholar 

  88. Ito R, Tamura K, Ashida H, Nishiwaki M, Nishioka A, Yamamoto Y, Furuyama J1, Utsunomiya J. Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary strictures. International Journal of Oncology 1998; 12(5):1019–1023.

    Google Scholar 

  89. Iwamoto KS, Mizuno T, Kurata A, Masuzawa M, Mori T, Seyama T. Multiple, unique, and common p53 mutations in a thorotrast recipient with four primary cancers. Human Pathology 1998; 29: 412–416.

    Article  PubMed  CAS  Google Scholar 

  90. Hruban RH, Sturm PD, Slebos RJ, Wilentz RE, Musler AR, Yeo CJ, Sohn TA, van Velthuysen ML, Offerhaus GJ. Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients. American Journal of Pathology 1997; 151: 943–949.

    PubMed  CAS  Google Scholar 

  91. Finkelstein S, Przygodzki RM, Swalsy PA. Microdissection-based P53 Genotyping: Recommendations for Molecular Testing. Molecular Diagnosis 2000, in press.

    Google Scholar 

  92. Marchesa P, et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. American Journal of Gastroenterology 1997; 92: 1285–1288.

    PubMed  CAS  Google Scholar 

  93. Pasha TM, Petz J, Ludwig J, Therneau TM, Benson JT, Malinchoc M., Dickson ER, Lindor KD. Incidence of cholangiocarcinoma in patients with primary sclerosing cholangitis. Hepatology 1997; 26: 170A.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liver Pathophysiology Laboratory, Department of Clinical Sciences, University of Rome “La Sapienza ”, Rome, Italy

    Sara D’Innocenzo, Francesca Russo, Lucia Miglioresi, Marco Bacosi & Giovanni L. Ricci

Authors
  1. Sara D’Innocenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesca Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lucia Miglioresi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Bacosi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giovanni L. Ricci
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgery, University of Rome “Tor Vergata”, Rome, Italy

    Attilio Maria Farinon (Professor of Surgery and Chairman) (Professor of Surgery and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

D’Innocenzo, S., Russo, F., Miglioresi, L., Bacosi, M., Ricci, G.L. (2002). The Evolutionary Pattern of Primary Sclerosing Cholangitis: From a Benign to Severe Disease. In: Farinon, A.M. (eds) Advances in Abdominal Surgery 2002. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0637-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-0637-7_5

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-6135-5

  • Online ISBN: 978-94-017-0637-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation